these data indicate that ciprofloxacin might be suitable for treatment of severe respiratory infections , especially pneumonia caused by pseudomonas aeruginosa , since the mics of ciprofloxacin for most bacteria involved in bronchopulmonary infections are very low and tissue diffusion of the drug in the respiratory tract is good .
C0032285
pneumonia
C0035237
respiratory tract